| REPL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the REPL shares outstanding history going back to 7/20/2018:
Also see: REPL Market Cap History REPL YTD Return |
REPL Shares Outstanding History — Replimune Group Share Count Over Time
As of 6/25/2026 Replimune Group has 83.95 million REPL shares outstanding. Investors often track the REPL shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows REPL share count trends over time, with 35 historical shares outstanding datapoints presented, dating back to 7/20/2018.
| REPL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REPL Historical Shares Outstanding: +13.45% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| REPL Stock Price Chart |
| About Replimune Group Inc |
| Replimune Group, Inc. a clinical-stage biotechnology company engaged in the development of a novel class of oncolytic immunotherapies. Co.'s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. RP1 (vusolimogene oderparepvec) is its lead product candidate and is based on a proprietary strain of herpes simplex virus engineered and genetically armed with a fusogenic protein (GALV-GP R-) and GM-CSF intended to maximize tumor killing potency, the immunogenicity of tumor cell death, and the activation of a systemic anti-tumor immune response. We show 35 historical shares outstanding datapoints in our coverage of REPL's shares outstanding history. Understanding the changing numbers of REPL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like REPL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching REPL by allowing them to research REPL shares outstanding history as well as any other stock in our coverage universe. |
| REPL Current Stock Quote |
Quotes delayed 20 minutes  Free REPL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| REPL Share Performance |
| Shares Outstanding Peers |
| Replimune Group (REPL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
REPR Shares Outstanding History RETA Shares Outstanding History REXN Shares Outstanding History RGEN Shares Outstanding History RGLS Shares Outstanding History RGNX Shares Outstanding History RIGL Shares Outstanding History RKTO Shares Outstanding History RLAY Shares Outstanding History RLMD Shares Outstanding History More Healthcare companies » |
REPL Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
